Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Consensus on the use of PPIs and antiplatelets

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Abraham NS, Hlatky MA, Antman EM, Bhatt DL, Bjorkman DJ, Clark CB, Furberg CD, Johnson DA, Kahi CJ, Laine L, Mahaffey KW, Quigley EM, Scheiman J, Sperling LS, Tomaselli GF.ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapyand NSAID Use. Journal of the American College of Cardiology 56: 2051-66, No. 24, 7 Dec 2010. Available from: URL: http://dx.doi.org/10.1016/j.jacc.2010.09.010

    2. 2.

      Voelker R.Experts OK antiplatelets and PPIs for heart patients with GI bleeding risks. JAMA: the Journal of the American Medical Association 305: 135-6, No. 2, 12 Jan 2011. Available from: URL: http://dx.doi.org/10.1001/jama.2010.1907

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Consensus on the use of PPIs and antiplatelets. React. Wkly. 1336, 1 (2011). https://doi.org/10.2165/00128415-201113360-00001

    Download citation

    Keywords

    • Clopidogrel
    • Omeprazole
    • Proton Pump Inhibitor
    • American Heart Association
    • Platelet Function